ANALYST RECOMMENDATIONS : Abbvie, Aerojet, Blackstone, Bristol-Myers Squibb, Ford...

Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.

 

• Abbvie: Morgan Stanley raises AbbVie's PT to $192 from $142, keeps Overweight rating
• AbioMed: Wolfe Research initiated coverage with a recommendation of peerperform. PT up 5.2% to $330.
• Aerojet: J.P. Morgan upgrades to overweight from neutral. PT up 22% to $49.
• Autonation: J.P. Morgan upgrades to overweight from neutral. PT up 33% to $130.
• Blackstone: Exane BNP Paribas downgrades to neutral from outperform. PT up 14% to $135.
• Brewin Dolphin: LBBW moves from Outperform to Market Perform targeting GBp 515.
• Bristol-Myers Squibb: Morgan Stanley downgrades  to Underweight from Equalweight, adjusts Price Target to $64 from $66
• Cullen/Frost Bankers: Wolfe Research upgrades to outperform from underperform. PT up 23% to $171.
• Dana: Barclays downgrades to equal-weight from overweight. PT up 12% to $18.
• Edwards Life: Wolfe Research initiated coverage with a recommendation of outperform. PT up 11% to $134.
• Ford: Barclays downgrades to equal-weight from overweight. PT up 10% to $17.
• Hays: Jefferies remains Buy with a price target reduced from GBp 205 to GBp 160.
• Inspire Medical: Wolfe Research initiated coverage with a recommendation of peerperform. PT up 5.4% to $270.
• Intuitive Surgical: Wolfe Research initiated coverage with a recommendation of peerperform. PT up 9.1% to $315.
• Lazard: Wolfe Research downgrades to underperform from peerperform. PT up 14% to $39.
• PageGroup: Jefferies downgrades from buy to hold targeting GBp 570.
• Masimo: Wolfe Research initiated coverage with a recommendation of peerperform. PT up 9.4% to $160.
• ResMed: Wolfe Research initiated coverage with a recommendation of outperform. PT up 13% to $280.
• Royalty Pharma: Morgan Stanley upgrades to Overweight from Equalweight, adjusts Price Target to $48 from $46
• RPM International: Fermium Research downgrades to hold from buy. PT up 5.6% to $92.
• Sonic Automotive: J.P. Morgan downgrades to neutral from overweight. PT up 36% to $57.
• Sthree: Jefferies maintains a Hold rating with a price target reduced from GBp 500 to GBp 430.